| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |